Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium.
Elisa ContiSimona AndreoniDavide TomaselliBenedetta StortiFrancesco BrovelliRoberto AcamporaFulvio Da ReIldebrando AppollonioCarlo FerrareseLucio TremolizzoPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
DBI may be a very promising candidate for AD, perhaps marking psychomotor DEL-like symptoms, in view of developing future helping tool for practicing physicians. Furthermore, DBI rise in DEL offers novel cues for a better comprehension of the pathogenesis of this potentially fatal condition.